SCHEMBL4050754

SCHEMBL4050754

[c]1ccc(OCc2cccc3ccccc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 2/20 0.57
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
FFAR1 O14842 1/20 0.54
AKR1B1 P15121 1/20 0.54
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CNR1 P21554 2/20 0.48
CNR2 P34972 2/20 0.48
SIRT2 Q8IXJ6 1/20 0.47
PARP15 Q460N3 1/20 0.45
LTA4H P09960 1/20 0.44
PLA2G2A P14555 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10349749 0.87 PARP10 (0.71) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL5609808 0.85 NPC1 (0.64) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL9034998 0.82 NPC1 (0.54) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL2516394 0.81 PARP10 (0.68) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL15249121 0.79 PARP10 (0.61) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL7252796 0.79 KDM4E (0.41) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL20024703 0.78 NPC1 (0.61) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL15249111 0.77 NPC1 (0.63) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL123733 0.77 FFAR1 (0.62) PARP10NPC1RAB9AMEN1KMT2A
SCHEMBL7247688 0.77 LOXL2 (0.50) LMNASMN1; SMN2NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365328-B1 Pyridine derivatives ZENECA LTD (GB) 1996-04-03 EP claimed
US-5053415-A Antiischemic, antiinflammatory, antiarthritic agents, cardiovascular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-10-01 US claimed
EP-0365328-A2 Pyridine derivatives ZENECA LIMITED (GB) 1990-04-25 EP claimed
CN-110249004-A Polyimide precursor composition 东京应化工业株式会社 2019-09-17 CN disclosed
CN-108389512-A The manufacturing method of laminated body, flexible devices and laminated body 东京应化工业株式会社 2018-08-10 CN disclosed
CN-108387954-A The manufacturing method of laminated body, flexible devices and laminated body 东京应化工业株式会社 2018-08-10 CN disclosed
CN-107429059-A ENERGY-SENSITIVE RESIN COMPOSITION 东京应化工业株式会社 2017-12-01 CN disclosed
EP-1397137-B1 HYDANTION DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES BRISTOL MYERS SQUIBB CO (US) 2009-10-14 EP disclosed
US-7482372-B2 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-27 US disclosed
EP-1558581-A4 TRIAZOLONE AND TRIAZOLETHIONE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2007-07-25 EP disclosed
US-7074810-B2 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme BRISTOL-MYERS SQUIBB COMPANY (US) 2006-07-11 US disclosed
EP-0831796-A1 METHOD FOR REDUCING OR PREVENTING POST-SURGICAL ADHESION FORMATION USING 5-LIPOXYGENASE INHIBITORS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 1998-04-01 EP disclosed
WO-1998004555-A1 NON-SYMMETRICAL BIS-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS ABBOTT LABORATORIES (US) 1998-02-05 WO disclosed
US-5668150-A ANTIALLERGY, ANTIINFLAMMATORY ABBOTT LABORATORIES (US) 1997-09-16 US disclosed
WO-1996040090-A1 METHOD FOR REDUCING OR PREVENTING POST-SURGICAL ADHESION FORMATION USING 5-LIPOXYGENASE INHIBITORS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 1996-12-19 WO disclosed
EP-0365328-B1 Pyridine derivatives ZENECA LTD (GB) 1996-04-03 EP disclosed
US-5358955-A Antiinflammatory agents ABBOTT LABORATORIES (US) 1994-10-25 US disclosed
US-5053415-A Antiischemic, antiinflammatory, antiarthritic agents, cardiovascular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-10-01 US disclosed
EP-0365328-A2 Pyridine derivatives ZENECA LIMITED (GB) 1990-04-25 EP disclosed
US-4035190-A 2-ISOXAZOLIN-3-HETEROCYCLIC-SUBSTITUTED MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1977-07-12 US disclosed